Lily L. Remsing Rix

Also affiliated with Moffitt Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Differential network analysis of ROS1 inhibitors reveals lorlatinib polypharmacology through co-targeting PYK2”.

Differential network analysis of ROS1 inhibitors reveals lorlatinib polypharmacology through co-targeting PYK2

Cell chemical biology(2023)10.1016/j.chembiol.2023.09.011

N/A

0.312DataRank · unranked

7 citations

Lily L. Remsing Rix, Xueli Li, Bin Fang, Victoria Izumi, Eric A. Welsh +6 more

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

Molecular Oncology(2025)10.1002/1878-0261.70155

N/A

0DataRank · unranked

0 citations

Lily L. Remsing Rix, Bin Fang, Eric A. Welsh, Nicole V. Bremer, Valentina Foglizzo +9 more